Virtus ETF Advisers’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-24,069
| Closed | -$379K | – | 485 |
|
|
2024
Q1 | $379K | Buy |
24,069
+3,463
| +17% | +$54.5K | 0.2% | 202 |
|
|
2023
Q4 | $332K | Sell |
20,606
-854
| -4% | -$13.8K | 0.21% | 204 |
|
|
2023
Q3 | $273K | Sell |
21,460
-2,773
| -11% | -$35.3K | 0.17% | 212 |
|
|
2023
Q2 | $341K | Buy |
24,233
+4,840
| +25% | +$68.1K | 0.2% | 165 |
|
|
2023
Q1 | $300K | Buy |
19,393
+341
| +2% | +$5.27K | 0.16% | 213 |
|
|
2022
Q4 | $312K | Sell |
19,052
-2,692
| -12% | -$44.1K | 0.16% | 246 |
|
|
2022
Q3 | $402K | Buy |
21,744
+317
| +1% | +$5.86K | 0.16% | 230 |
|
|
2022
Q2 | $282K | Buy |
+21,427
| New | +$282K | 0.1% | 271 |
|
|
2021
Q4 | – | Sell |
-12,686
| Closed | -$431K | – | 402 |
|
|
2021
Q3 | $431K | Sell |
12,686
-1,160
| -8% | -$39.4K | 0.19% | 160 |
|
|
2021
Q2 | $507K | Buy |
13,846
+2,867
| +26% | +$105K | 0.21% | 144 |
|
|
2021
Q1 | $492K | Buy |
10,979
+298
| +3% | +$13.4K | 0.21% | 149 |
|
|
2020
Q4 | $610K | Buy |
10,681
+5,003
| +88% | +$286K | 0.25% | 109 |
|
|
2020
Q3 | $291K | Sell |
5,678
-781
| -12% | -$40K | 0.15% | 231 |
|
|
2020
Q2 | $386K | Buy |
6,459
+887
| +16% | +$53K | 0.18% | 215 |
|
|
2020
Q1 | $229K | Sell |
5,572
-799
| -13% | -$32.8K | 0.09% | 270 |
|
|
2019
Q4 | $397K | Sell |
6,371
-5,422
| -46% | -$338K | 0.06% | 257 |
|
|
2019
Q3 | $400K | Sell |
11,793
-656
| -5% | -$22.3K | 0.08% | 188 |
|
|
2019
Q2 | $281K | Buy |
12,449
+1,871
| +18% | +$42.2K | 0.06% | 247 |
|
|
2019
Q1 | $246K | Sell |
10,578
-1,195
| -10% | -$27.8K | 0.52% | 79 |
|
|
2018
Q4 | $247K | Buy |
11,773
+355
| +3% | +$7.45K | 0.04% | 162 |
|
|
2018
Q3 | $442K | Sell |
11,418
-8,377
| -42% | -$324K | 0.05% | 144 |
|
|
2018
Q2 | $779K | Buy |
+19,795
| New | +$779K | 0.69% | 44 |
|